Your browser doesn't support javascript.
loading
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Wagner, Michael J; Zhang, Yuzheng; Cranmer, Lee D; Loggers, Elizabeth T; Black, Graeme; McDonnell, Sabrina; Maxwell, Shannon; Johnson, Rylee; Moore, Roxanne; Hermida de Viveiros, Pedro; Aicher, Lauri; Smythe, Kimberly S; He, Qianchuan; Jones, Robin L; Pollack, Seth M.
Afiliación
  • Wagner MJ; Medical Oncology, University of Washington, Seattle, Washington.
  • Zhang Y; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Cranmer LD; Seattle Cancer Care Alliance, Seattle, Washington.
  • Loggers ET; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Black G; Medical Oncology, University of Washington, Seattle, Washington.
  • McDonnell S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Maxwell S; Seattle Cancer Care Alliance, Seattle, Washington.
  • Johnson R; Medical Oncology, University of Washington, Seattle, Washington.
  • Moore R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Hermida de Viveiros P; Seattle Cancer Care Alliance, Seattle, Washington.
  • Aicher L; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Smythe KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • He Q; Medical Oncology, University of Washington, Seattle, Washington.
  • Jones RL; Medical Oncology, University of Washington, Seattle, Washington.
  • Pollack SM; Medical Oncology, University of Washington, Seattle, Washington.
Clin Cancer Res ; 28(11): 2306-2312, 2022 06 01.
Article en En | MEDLINE | ID: mdl-35349638

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leiomiosarcoma / Liposarcoma Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leiomiosarcoma / Liposarcoma Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article